NCT01408888 - A Study of LY2189265 and Sitagliptin in Participants With Type 2 Diabetes | Biotech Hunter

Enrollment

29

Participants

Timeline

Start Date

August 31, 2011

Primary Completion Date

April 30, 2012

Study Completion Date

April 30, 2012

Conditions

Diabetes Mellitus, Type 2

Interventions

BIOLOGICAL

LY2189265

Administered subcutaneously

DRUG

Sitagliptin

Administered orally

Trial Locations (3)

32117

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Daytona Beach

75247

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Dallas

96814

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Honolulu